SILVERIO, ANGELO
 Distribuzione geografica
Continente #
AS - Asia 5.070
NA - Nord America 2.997
EU - Europa 1.328
SA - Sud America 323
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 64
OC - Oceania 5
Totale 9.922
Nazione #
HK - Hong Kong 3.326
US - Stati Uniti d'America 2.897
SG - Singapore 802
IT - Italia 547
CN - Cina 320
VN - Vietnam 274
BR - Brasile 250
RU - Federazione Russa 213
DE - Germania 169
FR - Francia 82
FI - Finlandia 60
IN - India 57
BD - Bangladesh 56
IE - Irlanda 47
CA - Canada 44
TR - Turchia 39
KR - Corea 38
GB - Regno Unito 37
UA - Ucraina 37
MX - Messico 28
NL - Olanda 27
SE - Svezia 27
JP - Giappone 25
AR - Argentina 23
PL - Polonia 21
ID - Indonesia 20
ES - Italia 19
IQ - Iraq 19
ZA - Sudafrica 18
CO - Colombia 16
CZ - Repubblica Ceca 13
EC - Ecuador 13
SA - Arabia Saudita 13
PK - Pakistan 11
MA - Marocco 10
PH - Filippine 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
KE - Kenya 8
MY - Malesia 8
LU - Lussemburgo 7
EG - Egitto 6
JM - Giamaica 6
LT - Lituania 6
VE - Venezuela 6
KZ - Kazakistan 5
NP - Nepal 5
DZ - Algeria 4
LB - Libano 4
PS - Palestinian Territory 4
RO - Romania 4
AL - Albania 3
AU - Australia 3
EU - Europa 3
JO - Giordania 3
PA - Panama 3
TN - Tunisia 3
AT - Austria 2
AZ - Azerbaigian 2
BH - Bahrain 2
BZ - Belize 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
KW - Kuwait 2
LY - Libia 2
NI - Nicaragua 2
PY - Paraguay 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
ET - Etiopia 1
FJ - Figi 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
HR - Croazia 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LV - Lettonia 1
NE - Niger 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
Totale 9.781
Città #
Hong Kong 3.323
Singapore 442
San Jose 407
Ashburn 265
Milan 218
Ann Arbor 201
Dallas 197
Chandler 180
Council Bluffs 163
Beijing 103
Munich 101
Princeton 101
Wilmington 94
Ho Chi Minh City 84
Los Angeles 73
Houston 72
Lauterbourg 69
Rome 69
Woodbridge 54
Hanoi 53
New York 52
Jacksonville 49
Santa Clara 49
The Dalles 49
Boardman 48
Dublin 45
Turku 44
Dong Ket 43
Phoenix 30
São Paulo 29
Moscow 27
Memphis 26
Denver 23
Izmir 22
Montreal 22
Tokyo 21
Turin 21
Frankfurt am Main 19
Naples 19
Salerno 18
Warsaw 18
Andover 17
Orem 17
Washington 16
Amsterdam 15
Chicago 15
Mestre 15
Mexico City 15
Nanjing 14
Atlanta 13
Chennai 12
Johannesburg 12
Brno 11
Da Nang 11
Falls Church 11
Haiphong 10
Stockholm 10
Brooklyn 9
Nuremberg 9
Poplar 9
Rio de Janeiro 9
Seattle 9
Tashkent 9
Belo Horizonte 8
Boston 8
Pellezzano 8
Toronto 8
Brasília 7
Columbus 7
Fairfield 7
Figino 7
Helsinki 7
Palermo 7
Querétaro 7
San Francisco 7
Würselen 7
Ankara 6
Buffalo 6
Cairo 6
Manchester 6
Miami 6
Nairobi 6
New Delhi 6
Norwalk 6
Seoul 6
Baghdad 5
Bari 5
Bologna 5
Dammam 5
Dudelange 5
Florence 5
Guayaquil 5
London 5
Mumbai 5
Nanchang 5
Paris 5
Redwood City 5
Campinas 4
Changsha 4
Charlotte 4
Totale 7.432
Nome #
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction 944
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 531
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction 437
Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017 392
A novel MIR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathy 331
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives 297
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 250
Anterior mitral valve aneurysm perforation in a patient with preexisting aortic regurgitation 229
Polymorphisms of the antiapoptotic protein bag3 may play a role in the pathogenesis of tako-tsubo cardiomyopathy 199
Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia 193
Partial clip detachment and posterior mitral leaflet perforation after mitraclip implantation 173
Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation 168
Aortic dissection in patients with autosomal dominant polycystic kidney disease: a series of two cases and a review of the literature 164
Arterial Hypertension in Patients with Takotsubo Syndrome: Prevalence, Long-Term Outcome, and Secondary Preventive Strategies. A Report from the Takotsubo Italian Network Register 163
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement 162
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible Complications 156
Thrombus straddling a patent foramen ovale 153
Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment 152
Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19 137
Contemporary imaging in takotsubo syndrome 136
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 133
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 133
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 129
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 121
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 119
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 118
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19 116
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 111
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes 110
Transcatheter repair of functional mitral regurgitation in heart failure patients: A meta-analysis of 23 studies on mitraclip implantation 110
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 110
From Planning to Practice: Impact of Achieved Proximal Sealing Zone in Endovascular Aneurysm Repair (EVAR) 108
Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19 108
Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: The “BAV for life” experience 106
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI Registry 105
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients 104
Big Health Data and Cardiovascular Diseases: A Challenge for Research, an Opportunity for Clinical Care 99
Anti-Apoptotic BAG3 Gene in Tako-Tsubo Cardiomyopathy 98
Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? 95
A peculiar etiology of acute heart failure: adrenergic myocarditis 94
Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes 93
Reply 92
Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model 90
Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies 88
Biomarkers predict in-hospital major adverse cardiac events in covid-19 patients: A multicenter international study 88
Novel targets and strategies addressing residual cardiovascular risk in post-acute coronary syndromes patients 87
Artificial intelligence in cardiovascular prevention: new ways will open new doors 85
Clinical and Echocardiographic Features of Patients With Infective Endocarditis and Bicuspid Aortic Valve According to Echocardiographic Definition of Valve Morphology 83
Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging 81
Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report 80
How the COAPT trial affected the selection of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair: insights from the GIOTTO registry 75
Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study-The ISNEP Study 75
Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand? 74
Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low-Flow, Low-Gradient Aortic Stenosis 71
Dynamic Left Intraventricular Obstruction Phenotype in Takotsubo Syndrome 70
Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation 69
ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor 68
Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma 66
Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome 61
Cardiovascular Mortality in Takotsubo Syndrome 59
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 56
Prevalence and Prognostic Significance of Right Ventricular Dysfunction in Patients With Severe Low‐Flow, Low‐Gradient Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement 56
Editorial: Advances in Percutaneous Coronary Intervention 54
Response to: Correspondence on 'Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome' by John E Madias 50
Comparison of mortality in primary and secondary Takotsubo cardiomyopathy with severe left ventricular dysfunction: reply 50
Invasive and Non-invasive Assessment of Non-culprit Coronary Lesions in Patients with ST-segment Elevation Myocardial Infarction 49
Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients 49
Competing Risks of Cardiac and Noncardiac Mortality in Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair 47
Response to: Correspondence on 'Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome' by Chang et al 45
Consolidating the value of fondaparinux for current treatment of non-ST-elevation acute coronary syndromes 40
null 40
Echocardiographic tools for prognostic stratification in transthyretin cardiac amyloidosis: a new arrow in the quiver 39
Loeffler’s Endocarditis: An Integrated Multimodality Approach 38
Dual Antiplatelet Therapy with 3rd Generation P2Y12 Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose–Response 35
Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation 35
Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients 33
Predictors of thromboembolic events in Takotsubo syndrome: reply 33
Understanding changes in central nervous system function after transcatheter aortic valve replacement 24
Totale 9.922
Categoria #
all - tutte 29.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022184 0 0 0 2 11 8 6 13 24 18 25 77
2022/2023413 29 50 17 48 71 72 2 32 65 5 16 6
2023/2024353 11 36 35 14 33 67 6 9 0 17 13 112
2024/2025984 24 4 30 34 23 73 199 42 130 79 196 150
2025/20266.877 977 1.476 1.365 330 620 191 544 141 276 425 140 392
2026/2027319 133 160 26 0 0 0 0 0 0 0 0 0
Totale 9.922